Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000471381 | SCV000555881 | benign | Hypercholesterolemia, autosomal dominant, 3 | 2024-01-12 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000584672 | SCV000690979 | likely benign | Hypercholesterolemia, familial, 1 | 2017-10-08 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000471381 | SCV001257718 | uncertain significance | Hypercholesterolemia, autosomal dominant, 3 | 2018-05-03 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001284673 | SCV001470592 | benign | not specified | 2020-06-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV002225622 | SCV002504234 | likely benign | not provided | 2019-09-19 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001284673 | SCV002572384 | likely benign | not specified | 2022-08-27 | criteria provided, single submitter | clinical testing | |
New York Genome Center | RCV000471381 | SCV002764495 | uncertain significance | Hypercholesterolemia, autosomal dominant, 3 | 2021-12-17 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000471381 | SCV004844188 | likely benign | Hypercholesterolemia, autosomal dominant, 3 | 2024-01-11 | criteria provided, single submitter | clinical testing |